BCL2 and breast carcinoma: After being purified and characterized, GSF3 was found to inhibit MCF-7 breast cancer cell growth via the decreasing of Bcl-2 mRNA expression levels but the increasing of pro-(Bax)/anti-apoptotic (Bcl-2) mRNA expression ratios in the treated cells [18,28].